Sriram Venkataraman
Partner
Get their honest, personalized take on your startup.
Sign in to pitch Sriram →At a glance
- Full Name
- Sriram Venkataraman
- Title
- Partner
- Firm
- Avista Healthcare Partners
- Firm Type
- Healthcare-focused private equity firm
- Investment Stage
- Middle-market healthcare private equity; growth-oriented platform investments, buyouts, and add-on acquisitions
- Target Company Profile
- Healthcare companies with strong management teams, stable cash flows, robust growth prospects, and clear scale potential
- Sector Focus
- Outsourced pharma & medtech services; consumer healthcare; medical devices & medtech; specialty & generic pharmaceuticals; distribution & diagnostics; healthcare technology
- Geographic Focus
- Global healthcare businesses
- Location
- New York, NY
Background
Sriram Venkataraman is a Partner at Avista Healthcare Partners, a New York-based private equity firm focused exclusively on healthcare. Avista says Venkataraman joined the firm in 2007 and currently serves as a director of eMolecules, Probo Medical, Solmetex, Spear Education, and Terrats Medical.
Before Avista, Venkataraman was a Vice President in the Healthcare Investment Banking group at Credit Suisse, which he joined in 2001. Earlier in his career, he worked at GE Healthcare, formerly GE Medical Systems.
Venkataraman holds an M.S. in Electrical Engineering from the University of Illinois Urbana-Champaign and an M.B.A. with honors from The Wharton School at the University of Pennsylvania. His board history includes AngioDynamics, Inform Diagnostics, Lantheus Holdings, National Spine & Pain Centers, OptiNose, RVL Pharmaceuticals, and Zest Dental Solutions.
Investment Thesis & Focus
- Avista’s stated investment approach is healthcare-only and hands-on: “We look for businesses with strong management teams, stable cash flows and robust growth prospects.”
- The firm focuses on mid-sized companies in outsourced pharma & medtech services, consumer healthcare, medical devices & medtech, specialty & generic pharmaceuticals, distribution & diagnostics, and healthcare technology.
- Avista emphasizes operational value creation, including organic growth, add-on acquisitions, operational efficiency, financing structure, and support from healthcare Strategic Executives.
- Venkataraman’s board roles indicate particular exposure to healthcare products and services, including diagnostic imaging, dental products, pharma/biotech procurement, specialty pharma, and healthcare services.
- This is not a seed-stage angel profile based on verified sources; Avista is a private equity firm targeting growth-oriented healthcare businesses.
Notable Investments
- eMolecules - Current Avista portfolio company; tech-enabled procurement platform for hard-to-find R&D chemicals and bioreagents used in early-stage drug discovery.
- Probo Medical - Current portfolio company; global provider of diagnostic imaging equipment purchase, refurbishment, resale, and on-site service. Axios reported Avista’s 2022 majority investment at an estimated $450 million enterprise value.
- Solmetex - Current portfolio company; dental water-treatment and waste-management products, including mercury amalgam separation.
- Spear Education - Current portfolio company; tech-enabled provider of digital and in-person clinical training, practice analytics, and consulting for the dental market.
- Terrats Medical - Current portfolio company; Barcelona-based provider of dental prosthetics, including abutments, implants, and related products.
- Lantheus Medical Imaging - Exited portfolio company; radiopharmaceuticals and contrast agents for nuclear and ultrasound-based cardiovascular diagnostic imaging.
- OptiNose Healthcare - Exited portfolio company; specialty pharmaceutical company focused on ENT/allergy products using Exhalation Delivery Systems.
- Zest Dental Solutions - Exited portfolio company; dental products company known for its LOCATOR line of removable overdenture attachments.
Unlock the full research
Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.
One-time. Stays unlocked for you.